CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
AQST Aquestive Therapeutics
- 3.000
- 0.0000.00%
Close May 2 16:00 ET
- 3.048
- +0.048+1.60%
Post 20:01 ET
296.61MMarket Cap-5.88P/E (TTM)
3.049High2.940Low725.19KVolume3.010Open3.000Pre Close2.17MTurnover0.77%Turnover RatioLossP/E (Static)98.87MShares5.80052wk High-4.93P/B282.76MFloat Cap2.20052wk Low--Dividend TTM94.25MShs Float20.696Historical High--Div YieldTTM3.63%Amplitude0.618Historical Low2.996Avg Price1Lot Size
About Aquestive Therapeutics Company
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
Company Profile
SymbolAQST
Company NameAquestive Therapeutics
Listing DateJul 25, 2018
Issue Price15.00
Founded2004
CEOMr. Daniel Barber
MarketNASDAQ
Employees142
Fiscal Year Ends12-31
Address30 Technology Drive
CityWarren
ProvinceNew Jersey
CountryUnited States of America
Zip Code07059
Phone1-908-941-1900
Websitehttp://www.aquestive.com
Company Executives
- Name
- Position
- Salary
- Daniel Barber
- Chief Executive Officer, President and Director
- 4.18M
- Lori J. Braender
- Senior Vice President, General Counsel, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
- 1.82M
- Cassie Jung
- Chief Operating Officer
- --
- A. Ernest Toth, Jr
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Carl N. Kraus, M.D.
- Chief Medical Officer
- --
- Sherry Korczynski
- Senior Vice President, Sales and Marketing
- --
- Peter Boyd
- Senior Vice President, Information Technology, Human Resources and Communications
- --
- Dr. Melina T. Cioffi, Pharm.D.
- Senior Vice President, Regulatory Affairs
- --
- John S. Cochran
- Vice Chairman of the Board
- 156.61K
- Dr. Gregory B. Brown,M.D.
- Chairman of the Board
- 198.50K
- Abigail L. Jenkins, B.A.,M.S.
- Independent Director
- 190.23K
- Timothy E. Morris
- Independent Director
- 170.14K
- Dr. Marco Taglietti,M.D.
- Independent Director
- 147.26K
- Dr. Julie Krop, M.D.
- Independent Director
- 167.34K
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call